-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Will Aurora Cannabis Stock Be the Next Marijuana Stock to Breakout?
Cowen sees ACB stock doubling over the next year. That could happen, but only after a very specific catalyst materializes for Aurora Cannabis.
What You Should Expect From Marijuana Stocks That Make the ‘Jump’
We've seen it several times now: Marijuana stocks that make the jump to a well-known exchange can benefit greatly from the additional attention.
Aurora Cannabis Should Have Bought This Hemp Company
Aurora Cannabis missed a good opportunity this week to keep up with its peers, and ACB stock could suffer as a result.
Why Cronos Stock Isn’t Overvalued Here
After doubling in two months, CRON stock still isn't overvalued, but it also isn't the best pick in the cannabis space.
Don’t Stress Recent Weakness in Canopy Growth Stock
The recent near-10% drop in CGC stock is a healthy pullback before this stock takes its next big step forward later in 2019.
Invest Early Ahead of Business Trends
Individuals who want to grow wealth must get ahead of trends and invest early. Two such opportunities are becoming increasingly mainstream.
Is Canopy Growth Stock the Best Cannabis Play?
CGC stock has roughly doubled from its December lows to its January highs. Canopy Growth is good, but it needs time to digest that big rally.
As Cronos Stock Skyrockets, Should Investors Be Afraid?
Cronos shares have been climbing for months after Altria invested billions in the firm. Is it time to lock in CRON stock profits?
Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales?
Aurora Cannabis stock investors had mixed reactions to ACB's fiscal quarter results. Here's what you need to know about the company's results.
Should You Chase the Big Rally In Pyxus Stock?
Pyxus stock popped more than 25% after Q3 earnings, but fundamental challenges will likely cap further upside.
Are Marijuana Stocks Generally Overvalued?
Marijuana stocks like Aurora, Tilray and Canopy Growth have had a great past few months, but the reality is going to set in sooner or later.
Cannabis Stocks: Do Aurora or Canopy Earnings Matter?
Marijuana stocks like Aurora and Canopy Growth are highly volatile, and speculators would be to wise to buy only when they're down.
Amyris Stock Can Run Much Higher Than You Think
Amyris' move into cannabis has turned AMRS stock into a marijuana equity, and hemp legalization will help propel AMRS to multi-year highs.
Why Aurora Cannabis Stock Will Be the Biggest Winner – or the Biggest Loser – in Pot
Aurora Cannabis stock has risen nicely in 2019. But longer-term, ACB stock is likely to be either a big winner or a big loser.
It’s Time for Cronos Stock to Dive Back Down to Reality
The CRON stock price has gone parabolic, which means we all know how the party will end for Cronos Group.
Ride Cronos Stock’s Meteoric Rise … Before You Can’t
CRON is a hyper-momentum stock and there's no perfect time to buy it. Valuation aside, cannabis investing is young and the potential is great.
CRON Could Retest its $10 December Low
This morning I am recommending a bearish trade on Cronos Group, Inc. (NASDAQ:CRON), the Canada-based cannabis company.
